Bronchial challenge test in asthmatics sensitized to mites: role of particle size in bronchial response

Anne Casset1, Ashok Purohit, Emile Birba

  • 1Département de Pneumologie, Hôpital Lyautey, Hôpitaux Universitaires de Strasbourg, BP 426, 67091 Strasbourg, France.

Insights

House dust mite allergen particle size significantly impacts asthma responses. Larger particles trigger immediate bronchial reactions more effectively, suggesting their importance in clinical studies for mite-sensitized asthma patients.

Area of Science:

  • Allergy and Immunology
  • Respiratory Medicine
  • Pharmacology

Background:

  • House dust mite allergen (Der p 1) exposure is a key factor in asthma.
  • Standard bronchial challenge tests (BCT) may not accurately mimic real-world exposure due to small particle sizes.
  • The influence of allergen particle size on bronchial response requires further investigation.

Purpose of the Study:

  • To evaluate the impact of Dermatophagoides pteronyssinus extract particle size on bronchial reactivity in mite-sensitized individuals.
  • To compare bronchial responses using different mass median aerodynamic diameters (MMAD).
  • To assess the role of particle size in immediate and late-phase asthmatic reactions.

Main Methods:

  • Bronchial challenge tests (BCT) were conducted on 19 mite-sensitized patients using Der p 1 extract with MMADs of 1.1, 5.6, and 9.7 microm.
  • Bronchial response was measured by the provocative dose causing a 20% fall in FEV1 (PD20).
  • Interleukin-5 (IL-5) levels were measured in sputum and blood samples.

Main Results:

  • A significantly lower dose of Der p 1 was required to elicit a PD20 with larger particles (9.7 microm) compared to smaller particles (1.1 microm).
  • Large particles induced an early-phase asthmatic response more frequently (100%) than small particles (63%).
  • Smaller particles (1.1 microm) led to a greater increase in IL-5 levels in sputum and blood.

Conclusions:

  • Larger allergen particles play a significant role in the immediate bronchial response in mite-sensitized asthmatics.
  • Current BCT methods using small particles may underestimate the clinical impact of mite allergen exposure.
  • Future pharmacological studies should incorporate larger particle sizes to better reflect domestic exposure and clinical relevance.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
The Bronchial Tree01:23

The Bronchial Tree

The human bronchi and bronchial tree play a crucial role in the respiratory system, facilitating the exchange of oxygen and carbon dioxide. Let's delve into the intricate structure and functions of these respiratory components.
The trachea, commonly known as the windpipe, is a tube that connects the larynx (voice box) to the bronchi. At a point called the carina, it bifurcates into two primary bronchi. The right primary bronchus is wider, shorter, and more vertical than the left primary...